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Escherichia coli EDL933 Requires Gluconeogenic Nutrients To
Successfully Colonize the Intestines of Streptomycin-Treated Mice
Precolonized with E. coli Nissle 1917
Silvia A. C. Schinner,a Matthew E. Mokszycki,a Jimmy Adediran,a Mary Leatham-Jensen,a Tyrrell Conway,b Paul S. Cohena
Department of Cell and Molecular Biology, University of Rhode Island, Kingston, Rhode Island, USAa; Department of Microbiology and Plant Biology, University of
Oklahoma, Norman, Oklahoma, USAb
Escherichia coliMG1655, a K-12 strain, uses glycolytic nutrients exclusively to colonize the intestines of streptomycin-treated
mice when it is the only E. coli strain present or when it is confronted with E. coli EDL933, an O157:H7 strain. In contrast, E. coli
EDL933 uses glycolytic nutrients exclusively when it is the only E. coli strain in the intestine but switches in part to gluconeo-
genic nutrients when it colonizes mice precolonized with E. coliMG1655 (R. L. Miranda et al., Infect Immun 72:1666–1676,
2004, http://dx.doi.org/10.1128/IAI.72.3.1666-1676.2004). Recently, J. W. Njoroge et al. (mBio 3:e00280-12, 2012, http://dx.doi
.org/10.1128/mBio.00280-12) reported that E. coli 86-24, an O157:H7 strain, activates the expression of virulence genes under
gluconeogenic conditions, suggesting that colonization of the intestine with a probiotic E. coli strain that outcompetes O157:H7
strains for gluconeogenic nutrients could render them nonpathogenic. Here we report that E. coliNissle 1917, a probiotic strain,
uses both glycolytic and gluconeogenic nutrients to colonize the mouse intestine between 1 and 5 days postfeeding, appears to
stop using gluconeogenic nutrients thereafter in a large, long-term colonization niche, but continues to use them in a smaller
niche to compete with invading E. coli EDL933. Evidence is also presented suggesting that invading E. coli EDL933 uses both
glycolytic and gluconeogenic nutrients and needs the ability to perform gluconeogenesis in order to colonize mice precolonized
with E. coliNissle 1917. The data presented here therefore rule out the possibility that E. coliNissle 1917 can starve the O157:H7
E. coli strain EDL933 of gluconeogenic nutrients, even though E. coli Nissle 1917 uses such nutrients to compete with E. coli
EDL933 in the mouse intestine.
While much attention has been paid to the role of specificvirulence factors in bacterial pathogenesis, until recently lit-
tle attention has been paid to the roles of specific metabolic path-
ways in the ability of bacterial pathogens to initiate the pathogenic
process. Yet clearly, if a bacterial pathogen is unable to initiate
pathogenesis because nutrients essential for its growth are un-
available in the host, it will be unable to establish itself and cause
disease. Therefore, it is important to determine whether patho-
gens require glycolytic nutrients, gluconeogenic nutrients, or both
for success in invading and subsequently colonizing the host. In-
deed, recent studies have suggested that some pathogens use gly-
colytic nutrients, some use gluconeogenic nutrients, and some use
both to adapt to diverse host habitats (1–7).
We are interested in the nutritional basis of Escherichia coli
colonization of the intestine and particularly in whether precolo-
nization by commensal E. coli strains can be used to prevent in-
vadingE. coli intestinal pathogens fromcolonizing. CommensalE.
coli strains colonize the human intestine in the presence of a dense
and diverse intestinal microbiota comprising at least 500 cultiva-
ble species and 1013 to 1014 total bacteria (8). Unfortunately,E. coli
colonization cannot be studied experimentally in conventional
animals due to colonization resistance, which occurs when all
niches are filled by the microbiota (9). Such experiments require
an animal model with open niches for E. coli to colonize the intes-
tine in relatively high numbers, but to be authentic, the model
intestinemust also have a dense anddiverse anaerobic community
that matches the native microbiota of the conventional animal as
closely as possible. The streptomycin-treatedmousemodel is used
routinely for this purpose, since streptomycin-treated mice fulfill
these criteria (10, 11). Using this model, we have shown that for E.
coli to colonize, it must obtain nutrients in themucus layer, which
overlies the epithelium (10, 11), that it resides in the mucus layer
as amember ofmixed biofilms (12, 13), and that each E. coli strain
displays a unique nutritional program in the intestine (14).
E. coli strains can utilize both glycolytic and gluconeogenic
nutrients for growth in vitro, and we reported previously that
both E. coli MG1655, a commensal strain, and E. coli EDL933, an
O157:H7 pathogenic strain, use glycolytic but not gluconeogenic
nutrients to colonize the intestines of streptomycin-treated mice
when each is the only E. coli strain fed to mice (15). However, we
also reported that in the presence of E. coli MG1655, E. coli
EDL933 switches, at least in part, to gluconeogenesis in order to
maintain itself in the intestine, while E. coliMG1655 continues to
use glycolytic nutrients exclusively (15). These findings are of ex-
treme interest in view of recent reports showing that E. coli 86-24,
also anO157:H7 strain, activates the expression of virulence genes
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under gluconeogenic conditions (16, 17), because this suggests the
possibility that precolonization of the intestine with a probiotic E.
coli strain that starves E. coli O157:H7 strains of gluconeogenic
nutrients might render them nonpathogenic.
E. coliNissle 1917 is a commensal strain that has been used as a
probiotic agent to treat gastrointestinal infections in humans since
the early 1920s (18). Several features of E. coli Nissle 1917 have
been proposed to be responsible for its probiotic nature, including
its ability to express two microcins (19), the absence of known
protein toxins, its semirough lipopolysaccharide and hence its se-
rum sensitivity (20, 21), and the presence of six iron uptake sys-
tems (22).More recently, it has been shown that E. coliNissle 1917
inhibits the adherence of E. coli EDL933 to human epithelial cells
in vitro and simultaneously inhibits its growth and Shiga toxin 2
(Stx2) production (23). It has also been shown that in the intes-
tines of streptomycin-treated mice, E. coli Nissle 1917 is better
than a number of other commensal E. coli strains at limiting the
growth of E. coli EDL933 (12, 13). In this study, we examine
whether E. coliNissle 1917 uses both glycolytic and gluconeogenic
nutrients to colonize the intestines of streptomycin-treated mice
andwhetherE. coliEDL933 switches to gluconeogenic nutrients in
order to maintain itself in the intestines in the presence of E. coli
Nissle 1917.
MATERIALS AND METHODS
Bacterial strains.The bacterial strains used in this study are listed inTable
1. The original E. coli K-12 strain was obtained from a stool sample from
a convalescing diphtheria patient in Palo Alto, CA, in 1922 (24). The
sequenced E. coliMG1655 strain (CGSC 7740) was derived from the orig-
inal K-12 strain, having only been cured of the temperate bacteriophage
lambda and the F plasmid by means of UV light and acridine orange
treatment (24). It has an IS1 element in the flhDC promoter (25). E. coli
EDL933 is the prototype strain of enterohemorrhagic E. coli (EHEC)
O157:H7 (26). E. coli Nissle 1917 was originally isolated during World
War I from a soldier who escaped a severe outbreak of diarrhea (18). It has
a beneficial effect on several types of intestinal disorders, is well tolerated
by humans, and has been marketed as a probiotic remedy against intesti-
nal disorders in several European countries since the 1920s (18).
Media and growth conditions. LB broth (Lennox) (Difco Laborato-
ries,Detroit,MI), LB agar (Lennox) (Difco), andMacConkey agar (Difco)
were used for routine cultivation. SOCmediumwas prepared as described
by Datsenko and Wanner (27). For testing carbon and energy source
utilization in the Biolog system, M9 minimal medium (28) was modified
by the addition of 120mMNaCl tomore closely approximate the sodium
chloride concentration in the intestine (29).
Mutant construction. The allelic exchange method described by
Datsenko and Wanner (27) was used to construct E. coli Nissle 1917 Strr
pckA ppsA::cat (Table 1). The method allows the sequential construc-
tion of double deletion mutants by use of a removable chloramphenicol
cassette (27). The primers used to construct the deletion mutants were
designed according to the genome sequence of E. coliCFT073 (30), which
is closely related to that of E. coli Nissle 1917 (22). Deletions of 1,327 bp
and 2,367 bp were made in the pckA gene and the ppsA gene, respectively.
The pckA deletion primers used tomake E. coliNissle 1917 StrrpckA::cat
were as follows: primer 1, 5=-AGACTTTACTATTCAGGCAATACATAT
TGGCTAAGGAGCAGTGgtgtaggctggagctgcttcg-3=; primer 2, 5=-GCGG
GTATCTTTAATCGAGATACGTTTGCCAGTGCCGTTCCAgcatatgaat
atcctccttag-3= (capital letters, E. coli Nissle 1917 DNA; lowercase letters,
chloramphenicol resistance cassette DNA). The ppsA deletion primers
used to make E. coli Nissle 1917 Strr pckA ppsA::cat were as follows:
primer 1, 5=-GCGACTAAACGCCGCCGGGGATTTATTT TATTTCTTCA
GTgtgtaggctggagctgcttcg-3=; primer 2, 5=-AATGTGTTTCTCAAACCGTTC
ATTTATCACAAAAGGATTGTTCgcatatgaatatcctccttag-3= (capital letters,
E. coli Nissle 1917 DNA; lowercase letters, chloramphenicol resistance
cassette DNA). Gene knockouts were confirmed by PCR and sequencing
using the following upstream and downstream primers: pckA forward,
5=-GTTAATTATCGCATCCGGGCA-3=; pckA reverse, 5=-GTTGTCGA
TAAACAG TTTCGCCAG-3=;ppsA forward, 5=-CCTGTGTGGTTGCA
ATGTCCG-3=;ppsA reverse, 5=-TTGTTCTTCCCGTGATGCAGAC-3=.
DNA sequencing was carried out at the URI Genomics and Sequencing
Center, University of Rhode Island, Kingston, RI, using an Applied Bio-
systems 3130xl genetic analyzer (Applied Biosystems, Foster City, CA). A
BigDye Terminator cycle sequencing kit (version 3.1; Applied Biosys-
tems) was used for the sequencing reactions.
Biolog phenotypic analysis. For confirmation that E. coliNissle 1917
StrrpckAppsA::catwas able to grow on glycolytic substrates but unable
to grow on gluconeogenic substrates, this strain and its wild-type parent
were grown overnight inM9minimal medium containing 0.4% (vol/vol)
glycerol and 0.2 M NaCl at 37°C. Cultures were washed twice in M9
minimal medium containing 0.2 M NaCl without any carbon source and
were then diluted to an optical density at 600 nm (OD600) of 0.06 in 5 ml
of M9 minimal medium without any carbon source. Each culture was
diluted an additional 10-fold, and 100 l/well was added to a 96-well
microtiter plate (Biolog GN2 MicroPlate). Plates were incubated at 37°C
for 48 h in the OmniLog system. Levels of reduction of tetrazolium violet
dye were measured at 15-min intervals and were plotted against time,
resulting in a kinetic curve. E. coli Nissle 1917 and E. coli Nissle 1917
pckA ppsA each displayed the highest final level of tetrazolium reduc-
tion when either gluconate or glycerol was used as the sole carbon source.
Final levels of tetrazolium reduction on all other carbon sources were
normalized to that on glycerol.
TABLE 1 Bacterial strains
E. coli strain Genotype or phenotype
Designation in
the text
Source or
reference
Nissle 1917 Strr Spontaneous streptomycin-resistant mutant of E. coli Nissle 1917 E. coli Nissle 1917 42
Nissle 1917 Strr Nalr Spontaneous nalidixic acid-resistant mutant of E. coli Nissle 1917 Strr E. coli Nissle 1917 42
Nissle 1917 Strr
ppsA pckA::cat
ppsA pckA double deletion mutant of E. coli Nissle 1917 Strr carrying a
chloramphenicol resistance cassette in the ppsA deletion; unable to metabolize
gluconeogenic substrates
E. coli Nissle 1917
ppsA pckA
This study
MG1655 Strr Nalr Spontaneous streptomycin- and nalidixic acid-resistant mutant of E. coli MG1655 E. coli MG1655 15
EDL933 Strr Spontaneous streptomycin-resistant mutant of E. coli EDL933 E. coli EDL933 15
EDL933 Strr Rifr Spontaneous rifampin-resistant mutant of E. coli EDL933 Strr E. coli EDL933 36
EDL933 Strr ppsA
pckA::cat
ppsA pckA double deletion mutant of E. coli EDL933 Strr carrying a
chloramphenicol resistance cassette in the ppsA deletion; unable to metabolize
gluconeogenic substrates
E. coli EDL933
ppsA pckA
15
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Mouse colonization experiments. The specifics of the streptomycin-
treated mouse model, used to compare the large-intestine-colonizing
abilities of E. coli strains in mice, have been described previously (12).
Briefly, sets of three male CD-1 mice (5 to 8 weeks old) were given drink-
ing water containing streptomycin sulfate (5 g/liter) for 24 h to eliminate
resident facultative bacteria (31). Following 18 h of starvation for food
and water, the mice were fed 1 ml of 20% (wt/vol) sucrose containing 105
CFU of LB broth (Lennox)-grown E. coli strains, as described in Results.
After ingestion of the bacterial suspension, both the food (Teklad mouse
and rat diet; Harlan Laboratories, Madison, WI) and the streptomycin-
containing water were returned to the mice, and 1 g of feces was collected
after 5 h and 24 h and on odd-numbered days, at the times indicated in the
figures.Mice were housed individually in cages without bedding andwere
placed in clean cages at 24-h intervals. Individual fecal pellets were there-
fore no older than 24 h. Each fecal sample (1 g) was homogenized in 10ml
of 1% Bacto tryptone (Difco), diluted in the samemedium, and plated on
MacConkey agar plates with appropriate antibiotics.When appropriate, 1
ml of a fecal homogenate (sampled after the large debris had settled) was
centrifuged at 12,000  g, resuspended in 100 l of 1% Bacto tryptone,
and plated on a MacConkey agar plate with appropriate antibiotics. This
procedure increased the sensitivity of the assay from 102 CFU/g of feces to
10 CFU/g of feces. To distinguish the various E. coli strains in feces, dilu-
tions were plated on lactose MacConkey agar containing streptomycin
sulfate (100 g/ml) either alone or together with nalidixic acid (50 g/
ml), chloramphenicol (30 g/ml), or rifampin (50 g/ml). Streptomycin
sulfate, chloramphenicol, and nalidixic acid were purchased from Sigma-
Aldrich (St. Louis, MO). All plates were incubated for 18 to 24 h at 37°C
prior to counting. Each colonization experiment was performed at least
twice, with essentially identical results. Pooled data from at least two in-
dependent experiments (for a total of six mice) are presented in the fig-
ures. All animal protocols were approved by theUniversity Committee on
Use and Care of Animals at the University of Rhode Island.
FISH. Fluorescence in situ hybridization (FISH) was performed as
described previously (12, 32). Briefly, the cecumof amouse designated for
FISH was cut into 1- to 2-cm pieces, suspended in Tissue-Tek OCT com-
pound (Sakura, Torrance, CA), and snap-frozen in 2-methylbutane sus-
pended in liquid nitrogen. Pieces were then stored at 80°C until ready
for sectioning. For sectioning, the UltraPro 5000 cryostat (Vibratome, St.
Louis, MO) was used to cut 10-m sections, which were adhered to poly-
L-lysine-treated slides for visualization. Slides were fixed in 4% parafor-
maldehyde for 1 h at room temperature, followed by awash in phosphate-
buffered saline for 10min. Slideswere allowed to air dry overnight prior to
hybridization. Fluorescent probes (Integrated DNA Technologies [IDT],
Coralville, IA) were diluted in hybridization solution (0.1 M Tris-HCl
buffer [pH7.2], 0.9MNaCl, and 0.1%SDS). TheE. coli 23S rRNA-specific
Cy3-conjugated probe (5=-Cy3-CACCGTAGTGCCTCGTCATCA-3=)
(red) and the eubacterial 23S rRNA-specific FAM (6-carboxyfluorescein)
probe (5=-GCTGCCTCCCGTAGGAGT-FAM-3=) (green) were used at
concentrations of 5 g/l and 25 g/l, respectively. Subsequently, 10 l
of diluted probes in hybridization solution was pipetted onto each slide.
Each slide was then covered with a HybriSlip hybridization cover (Life
Technologies, Carlsbad, CA) andwas allowed to incubate in the dark for 2
h at 50°C. The slides were then placed in a wash buffer (0.1 M Tris-HCl
buffer [pH 7.2] and 0.9 M NaCl) and were allowed to soak for 20 min at
50°C. Slides were then rinsed with distilled water and were air dried over-
night. Sections were viewed by confocal microscopy. Prior to viewing,
sections on the poly-L-lysine treated slides were treated with Vectashield
mounting medium (Vector Laboratories, Burlingame, CA), an anti-
bleaching agent that helps prolong fluorescence for imaging.
Statistics. The colonization data for E. coli EDL933 from day 17
through day 21 in Fig. 3A were combined, as were the corresponding data
in Fig. 6A, and these Fig. 3A data and Fig. 6A data were compared by a
two-tailed Student t test. Also, the colonization data for E. coli MG1655
fromday 17 through day 21 in Fig. 2A andBwere combined, as were those
for E. coli Nissle 1917 from day 17 through day 21 in Fig. 3A and B, and
these data for the two strains were compared by a two-tailed Student t test.
P values of0.05 were interpreted as indicating a significant difference.
RESULTS
E. coli Nissle 1917 uses glycolytic and gluconeogenic nutrients
for growth in the mouse intestine. We reported previously that
both E. coli MG1655, a commensal strain, and E. coli EDL933, an
O157:H7 strain, use glycolytic but not gluconeogenic nutrients to
colonize the intestines of streptomycin-treated mice when each is
the only E. coli strain fed to mice (15). It was of interest to deter-
mine whether the same is true of E. coli Nissle 1917, an effective
probiotic strain (18). Phosphoenolpyruvate carboxykinase con-
verts oxaloacetate to phosphoenolpyruvate and is encoded by the
E. coli pckA gene (33). Phosphoenolpyruvate synthase is encoded
by the E. coli ppsA gene and converts pyruvate to phosphoenolpy-
ruvate (34). Since the conversion of tricarboxylic acid (TCA) cycle
intermediates to phosphoenolpyruvate is completely blocked in a
ppsA pckA double mutant, this mutant is unable to grow on glu-
coneogenic nutrients, such as acetate, pyruvate, amino acids that
feed into the TCA cycle, fatty acids, and TCA cycle intermediates,
as sole carbon and energy sources but should be able to grow on
phosphoenolpyruvate and amino acids that feed into the central
carbon metabolism “above” pyruvate, as long as the wild-type
strain can do so (35). Also, since glycolytic pathways are not af-
fected in a ppsA pckA doublemutant, thismutant should be able to
grow as well as the wild type on sugars as sole carbon and energy
sources (35). An E. coli Nissle 1917 ppsA pckA mutant was
constructed and, as expected, failed to grow on gluconeogenic
nutrients butwas still able to grow aswell as wild-typeE. coliNissle
1917 on glycolytic nutrients (Table 2). Next, we tested the abilities
of these strains to colonize mouse intestines.
When 105 CFU of E. coli Nissle 1917 and 105 CFU of E. coli
Nissle 1917ppsApckAwere fed simultaneously tomice, by day
1 postfeeding, each had grown 2 orders of magnitude, suggesting
that E. coli Nissle 1917 did not use gluconeogenic nutrients for
growth in the intestine during that initial period, presumably be-
cause glycolytic nutrients were plentiful (Fig. 1). However, from
TABLE 2 Biolog phenotypic analysis of E. coli Nissle 1917 strains grown
on glycolytic and gluconeogenic carbon sources
Carbon source
Relative final tetrazolium dye reduction
levela
E. coli
Nissle 1917
E. coli Nissle 1917
ppsA pckA
Galactose 0.81 0.81
Gluconate 1.00 1.00
Glucose 0.65 0.65
Glycerol 1.00 1.00
Mannose 0.81 0.81
Alanine 0.52 0.05
Aspartate 0.68 0.05
Proline 0.65 0.05
Pyruvic acid methyl ester 0.68 0.05
Serine 0.65 0.05
Succinate 0.97 0.05
a E. coli Nissle 1917 Strr Nalr and E. coli Nissle 1917 Strr pckA ppsA::cat each
displayed the highest final level of tetrazolium reduction when either gluconate or
glycerol was used as the sole carbon source (see Materials and Methods). Final levels of
tetrazolium reduction on all other carbon sources were normalized to that on glycerol.
Results for only 11 of 96 carbon sources tested are shown.
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day 1 to day 5 postfeeding, E. coli Nissle 1917 remained in the
intestine in relatively constant numbers, whereas the numbers of
E. coli Nissle 1917 ppsA pckA bacteria dropped 2 orders of
magnitude, suggesting that during that period, glycolytic nutri-
ents were in short supply, forcing E. coli Nissle 1917 to switch, at
least in part, to gluconeogenic nutrients, which E. coliNissle 1917
ppsA pckA was unable to do (Fig. 1). Since we already have
established that E. coli Nissle 1917 uses glycolytic nutrients for
colonization (14), these results also suggest that E. coliNissle 1917
uses both glycolytic and gluconeogenic nutrients for growth in the
mouse intestine between day 1 and day 5 postfeeding. Beyond day
5 postfeeding, the ratio of E. coli Nissle 1917 to E. coli Nissle 1917
ppsA pckA remained fairly constant (Fig. 1), suggesting either
that E. coli Nissle 1917 stopped using gluconeogenic nutrients for
growth in the intestine or that E. coli Nissle 1917 ppsA pckA
maintained itself in constant numbers by switching to the use of
one or more glycolytic nutrients not being used by E. coli Nissle
1917. Since there is no obvious reason why E. coli Nissle 1917
ppsA pckA would use glycolytic nutrients not being used by E.
coli Nissle 1917, we favor the hypothesis that beyond day 5 post-
feeding, E. coli Nissle 1917 and E. coli Nissle 1917 ppsA pckA
colonized an intestinal niche in which glycolytic nutrients were in
ample supply, so that the use of gluconeogenic nutrients was not
necessary, and therefore, E. coli Nissle 1917 stopped using them
for growth. For discussion purposes, wewill assume that this is the
case. In contrast to the 2- to 3-order-of-magnitude advantage that
E. coli Nissle 1917 displayed in the intestine when 105 CFU of
wild-type E. coli Nissle 1917 and 105 CFU of E. coli Nissle 1917
ppsA pckA were fed simultaneously to mice, the colonization
abilities of these strains were identical when they were fed sepa-
rately, each colonizing at about 109 CFU/g of feces (compare Fig. 3
and 6). Parenthetically, these data make it unlikely that growth or
survival in feces has a differential effect on either strain and
thereby validate the use of fecal counts to measure their relative
colonizing abilities when both strains are fed to mice simultane-
ously.
E. coli EDL933 ppsA pckA is nearly eliminated from the
intestines of mice precolonized with E. coliNissle 1917, but not
with E. coli MG1655. Humans infected with E. coli O157:H7
strains are presumably colonized with at least one commensal E.
coli strain prior to infection. To mimic that situation, streptomy-
cin-treated mice can be precolonized with a commensal E. coli
strain for 10 days and then fed E. coli EDL933 (14, 36).Whenmice
were precolonized with the commensal E. coli strain MG1655
for 10 days and were then fed 105 CFU each of wild-type E. coli
EDL933 and E. coli EDL933 ppsA pckA, wild-type E. coli
EDL933 grew to a level between 106 and 107 CFU/g of feces,
whereasE. coliEDL933ppsApckA dropped to about 103CFU/g
of feces (Fig. 2A), suggesting, as reported previously (15), that
under these conditions, E. coli EDL933 uses both glycolytic and
gluconeogenic nutrients for colonization. In contrast, inmice pre-
colonizedwith E. coliMG1655 for 10 days and then fed 105 CFUof
E. coli EDL933 ppsA pckA but no wild-type E. coli EDL933, the
gluconeogenesis mutant maintained itself at a level between 105
FIG 1 Colonization of the intestines of streptomycin-treated mice by E. coli
Nissle 1917 and E. coliNissle 1917ppsApckA. Two sets of 3 mice each were
fed 105 CFU of E. coli Nissle 1917 Strr Nalr () and 105 CFU of E. coli Nissle
1917 Strr ppsA pckA::cat (Œ). At the indicated times, fecal samples were
homogenized, diluted, and plated as described inMaterials andMethods. Data
are mean log10 CFU per gram of feces for each time point; error bars represent
standard errors.
FIG 2 Colonization of the intestines of streptomycin-treated mice by pread-
ministered E. coli MG1655, E. coli EDL933, and E. coli EDL933 ppsA pckA.
(A) Three sets of 3 mice were fed 105 CFU of E. coliMG1655 Strr Nalr on day 0
() and 105 CFU each of E. coli EDL933 Strr Rifr () and E. coli EDL933 Strr
ppsApckA::cat (Œ) on day 10 postfeeding. (B) Three sets of 3 mice were fed
105 CFU of E. coli MG1655 Strr Nalr on day 0 () and 105 CFU of E. coli
EDL933 Strr ppsA pckA::cat (Œ) on day 10 postfeeding. At the indicated
times, fecal samples were homogenized, diluted, and plated as described in
Materials and Methods. Data are mean log10 CFU per gram of feces for each
time point; error bars represent standard errors.
Schinner et al.
1986 iai.asm.org May 2015 Volume 83 Number 5Infection and Immunity
 o
n
 January 30, 2019 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
and 106 CFU/g of feces, 100-fold higher than the level in the pres-
ence of wild-type E. coli EDL933 (Fig. 2B), suggesting that in the
absence of wild-type E. coli EDL933, enough glycolytic nutrients
were available for E. coliEDL933ppsApckA to sustain that level
in the intestine. In similar experiments, when mice were precolo-
nized with E. coli Nissle 1917 for 10 days and were then fed 105
CFU each of wild-type E. coli EDL933 and E. coli EDL933 ppsA
pckA, wild-type E. coli EDL933 grew to a level between 105 and
106 CFU/g of feces, whereas E. coli EDL933 ppsA pckA was
nearly eliminated, dropping to about 102 CFU/g of feces (Fig. 3A).
Moreover, in the absence of wild-type E. coli EDL933, E. coli
EDL933 ppsA pckA levels still dropped to about 102 CFU/g of
feces inmice precolonized with E. coliNissle 1917 for 10 days (Fig.
3B), suggesting that in mice precolonized with E. coliNissle 1917,
invading E. coli EDL933must use both the available glycolytic and
gluconeogenic nutrients to maintain itself in the intestine; i.e., the
available concentration of glycolytic nutrients alone is not suffi-
cient. Furthermore, since in the absence of wild-type E. coli
EDL933, E. coli EDL933 ppsA pckA colonized mice precolo-
nized with E. coliNissle 1917 for 10 days at a level 1,000-fold lower
than that for mice precolonized with E. coli MG1655 for 10 days
(compare Fig. 2B and 3B), it appears that far fewer glycolytic nu-
trients were available to E. coli EDL933 in E. coli Nissle 1917-
precolonized mice than in E. coli MG1655-precolonized mice.
In the absence of precolonizationwith any commensalE. coli
strain, E. coli EDL933 and E. coli EDL933 ppsA pckA fed to
mice treated with streptomycin for 10 days colonize mouse in-
testines equally well. The data to this point suggested that pre-
colonization of mouse intestines with E. coliNissle 1917 leaves far
fewer glycolytic nutrients available to invading E. coli EDL933
than does precolonization with E. coli MG1655, raising the possi-
bility that E. coli EDL933 competes for glycolytic nutrients only/
mainlywith the preadministeredE. coli strain andnotwith the rest
of the microbiota. To determine whether E. coli EDL933 does or
does not compete with the microbiota to colonize, mice were
treated with streptomycin but were not precolonized with any E.
coli strain. At day 10, the mice were fed 105 CFU each of E. coli
EDL933 and E. coli EDL933ppsApckA. Indeed, the two strains
grew at the same rate in mouse intestines for 3 days, to a level of
about 109 CFU/g of feces, and cocolonized intestines at a level of
about 108 CFU/g of feces thereafter (Fig. 4). These results suggest
that in the absence of E. coli MG1655, E. coli Nissle 1917, or any
other E. coli strain, glycolytic nutrients were in sufficient supply in
the intestine such that a switchover to gluconeogenic nutrients by
E. coli EDL933was not necessary. Parenthetically, the results show
that E. coli EDL933 and E. coli EDL933ppsApckA grow/survive
equally well in feces, thus validating the use of fecal plate counts in
experiments comparing the two strains in mice.
Visualization of a dense and diverse microbiota in the cecal
mucus of mice treated with streptomycin for 10 days. E. coli
strains colonize the large intestines of streptomycin-treated mice
by growing in the mucus layer as members of mixed biofilms (12,
13), and the glycolytic nutrients they use for growth appear to be
mono- and disaccharides produced by the anaerobes as extracel-
lular degradation products of oligo- and polysaccharides (14, 37,
FIG 3 Colonization of the intestines of streptomycin-treated mice by pread-
ministered E. coli Nissle 1917, E. coli EDL933, and E. coli EDL933 ppsA
pckA. (A) Four sets of 3 mice were fed 105 CFU of E. coliNissle 1917 Strr Nalr
on day 0 () and 105 CFU each of E. coli EDL933 Strr Rifr () and E. coli
EDL933 Strr ppsA pckA::cat (Œ) on day 10 postfeeding. (B) Four sets of 3
micewere fed 105CFUofE. coliNissle 1917 StrrNalr on day 0 () and 105CFU
of E. coli EDL933 Strr ppsA pckA::cat (Œ) on day 10 postfeeding. At the
indicated times, fecal samples were homogenized, diluted, and plated as de-
scribed in Materials and Methods. Data are mean log10 CFU per gram of feces
for each time point; error bars represent standard errors.
FIG 4 Colonization of the intestines of streptomycin-treated mice by E. coli
EDL933 and E. coli EDL933 ppsA pckA 10 days after streptomycin treat-
ment. Two sets of 3mice were fed 105 CFU each of E. coli EDL933 Strr Rifr ()
and E. coli EDL933 StrrppsApckA::cat (Œ) 10 days after streptomycin treat-
ment had begun. Streptomycin treatment was continued for the duration of
the experiment. At the indicated times, fecal samples were homogenized, di-
luted, and plated as described in Materials and Methods. Data are mean log10
CFU per gram of feces for each time point; error bars represent standard
errors.
Gluconeogenesis and Intestinal Colonization
May 2015 Volume 83 Number 5 iai.asm.org 1987Infection and Immunity
 o
n
 January 30, 2019 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
38). Clearly, there were sufficient mono- and disaccharides in the
intestines of mice fed streptomycin for 10 days in the absence of
any precolonizing E. coli strain to allow E. coli EDL933 to grow to
high numbers without using gluconeogenic nutrients (Fig. 4),
suggesting that if a robust anaerobe population was present, it was
producing mono- and disaccharides but not using them for
growth. Indeed, the cecal mucus layer in mice fed streptomycin
for 10 days in the absence of any precolonizing E. coli strain did
contain a large and diverse microbiota consisting of members of
various sizes and shapes, but no E. coli (Fig. 5A). As expected, E.
coli was present in the cecal mucus of mice precolonized with E.
coli Nissle 1917 for 10 days (Fig. 5B).
Growth of E. coli EDL933 and E. coli EDL933 ppsA pckA
in the intestines of mice precolonized with E. coli Nissle 1917
ppsA pckA. The data presented in Fig. 1 suggested that E. coli
Nissle 1917 uses gluconeogenic nutrients for growth in the mouse
intestine between day 1 and day 5 postfeeding but then stops using
them. However, when mice were precolonized with E. coli Nissle
1917 ppsA pckA for 10 days and were then fed 105 CFU each of
wild-type E. coli EDL933 and E. coli EDL933 ppsA pckA, wild-
type E. coli EDL933 grew to about 107 CFU/g of feces (Fig. 6A), a
level 10-fold higher than that in mice precolonized with wild-
type E. coli Nissle 1917 (P  0.00001) (compare Fig. 3A and 6A,
and see Materials and Methods for an explanation of P values),
suggesting that E. coli Nissle 1917 does use gluconeogenic nutri-
ents to limit the growth ofE. coliEDL933 (Fig. 1).Moreover,E. coli
EDL933 ppsA pckA was nearly eliminated, dropping to about
102 CFU/g of feces (Fig. 6A), suggesting that E. coli EDL933 uses
both glycolytic and gluconeogenic nutrients for growth in mice
precolonized with E. coli Nissle 1917 ppsA pckA.
We wanted to test further whether E. coliNissle 1917 uses glu-
coneogenic nutrients to limit the growth of E. coli EDL933 in the
mouse intestine, as suggested by the preceding experiment. If E.
coliNissle 1917 was not using gluconeogenesis to limit the growth
of E. coli EDL933, precolonization with E. coli Nissle 1917 ppsA
pckA should limit colonization by E. coli EDL933 ppsA pckA
as well as precolonization with wild-type E. coli Nissle 1917 does.
However, we found that E. coli EDL933 ppsA pckA colonized
the intestines of mice precolonized with E. coliNissle 1917 ppsA
pckA at a level between 105 and 106 CFU/g of feces (Fig. 6B),
1,000-fold higher than the level inmice precolonizedwith E. coli
Nissle 1917 (compare Fig. 3B and 6B). Therefore, it appears thatE.
coli Nissle 1917 does use gluconeogenic nutrients to nearly elimi-
nate E. coli EDL933 ppsA pckA from the mouse intestine, de-
spite appearing to stop using gluconeogenic nutrients 5 days post-
feeding (Fig. 1).
DISCUSSION
It was reported recently that E. coli 86-24, an O157:H7 strain,
activates the expression of virulence genes under gluconeogenic
conditions (16, 17). The present study was undertaken to deter-
mine whether E. coli Nissle 1917, routinely used as a probiotic
agent, depletes gluconeogenic nutrients by using them for growth
in the mouse intestine, thereby preventing E. coli EDL933, also an
O157:H7 strain, from activating virulence gene expression. We
found that E. coli Nissle 1917 does indeed use gluconeogenic nu-
trients to colonize the mouse intestine (Fig. 1). Yet we also found
that E. coli EDL933 relies heavily on gluconeogenesis to colonize
mice precolonized with E. coli Nissle 1917 for 10 days; i.e., under
these conditions, wild-type E. coli EDL933 colonized at a level
almost 10,000-fold higher than that of E. coli EDL933 ppsA
pckA at day 21 (Fig. 3A). These data eliminate the possibility that
E. coli Nissle 1917 depletes the intestine of gluconeogenic nutri-
ents and therefore show that E. coliNissle 1917 would not prevent
the activation of virulence gene expression by E. coli EDL933, as-
suming that virulence gene expression is activated in E. coli
EDL933 as it is in E. coli 86-24. We also showed that only under
conditions in which E. coli EDL933 competes for nutrients with
precolonizing E. coli strains does it utilize gluconeogenic nutrients
FIG 5 In situ hybridization with fluorescence-labeled oligonucleotide probes.
Ten days after mice were sham fed without E. coli (A), and 10 days after mice
were fed E. coli Nissle 1917 Strr Nalr (B), cecal mucosal sections were hybrid-
ized with an E. coli-specific oligonucleotide probe (red) and a eubacterium-
specific oligonucleotide probe (green). EP, epithelium. E. coli cells appear red,
while all other bacteria appear green.
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for growth in the mouse intestine; i.e., in mice that had not been
precolonizedwith anyE. coli strain, but that contained a dense and
apparently diverse microbiota (Fig. 5A), wild-type E. coli EDL933
and E. coli EDL933 ppsA pckA grew at the same rate, to about
109 CFU/g of feces, and cocolonized mice equally well thereafter,
at about 108 CFU/g of feces (Fig. 4).
Despite the finding that E. coli EDL933 switches in part to
gluconeogenesis in both E. coli MG1655- and E. coli Nissle 1917-
precolonizedmice (Fig. 2 and 3), differences in the competition of
E. coli EDL933ppsApckA against E. coliMG1655 and against E.
coliNissle 1917were observed. That is, inmice precolonized for 10
days with E. coli Nissle 1917 and fed 105 CFU of E. coli EDL933
ppsApckA, the gluconeogenesis mutant was nearly eliminated,
colonizing at a level of only 102 CFU/g of feces (Fig. 3B). In con-
trast, in mice precolonized with E. coli MG1655 and fed 105 CFU
of E. coli EDL933 ppsA pckA, the gluconeogenesis mutant col-
onized at a level of 105 CFU/g of feces, 1,000-fold higher than the
level inmice precolonizedwithE. coliNissle 1917 (Fig. 2B). There-
fore, it appears that glycolytic nutrientswere less available toE. coli
EDL933 inmice precolonized with E. coliNissle 1917 than inmice
precolonized with E. coli MG1655. In support of this view, E. coli
Nissle 1917 colonized the intestine at a level about 10-fold higher
than E. coli MG1655 (P  0.00001) (compare Fig. 2 and 3) and
presumably used more glycolytic nutrients in the process, leaving
fewer glycolytic nutrients for E. coli EDL933.
We also found that E. coli Nissle 1917 uses gluconeogenic nu-
trients for growth in the intestines of streptomycin-treated mice
between day 1 and day 5 postfeeding but appears to stop using
them thereafter (Fig. 1). Paradoxically, we found that gluconeo-
genic nutrients are used by precolonizing E. coliNissle 1917 at and
beyond 10 days postfeeding to limit the growth of invading E. coli
EDL933 (Fig. 3A and B). How, then, does precolonizing E. coli
Nissle 1917 appear to stop using gluconeogenic nutrients that are
available in themouse intestine beyond 5 days postfeeding and yet
use them to limit the growth of invading E. coli EDL933 at 10 days
postfeeding? This paradox can be explained if beyond 5 days post-
feeding, E. coli Nissle 1917 resides both in a large niche in the
mouse intestine, in which it uses only glycolytic nutrients, and in a
much smaller niche, where it competes with invading E. coli
EDL933 for both glycolytic and gluconeogenic nutrients. This ex-
planation fits well with our “restaurant” hypothesis, which we
summarize immediately below andwhichwe recently proposed to
account for the fact that E. coli mutants that grow poorly relative
to their parents in bacterium-free cecal mucus in vitro can colo-
nize the mouse intestine better than their parents (12, 13).
It is known that to grow in and colonize the mouse large intes-
tine, E. coli strains must penetrate into the mucus layer (10, 11). It
is also known that E. coli strains reside in mucus as members of
mixed biofilms (12, 13). Furthermore, E. coli strains use mono-
and disaccharides as glycolytic nutrients for growth in the mouse
large intestine (14, 37), yet mono- and disaccharides are absorbed
in the small intestine. Since most E. coli strains do not secrete
extracellular polysaccharide hydrolases (38–40) and therefore
cannot degrade dietary-fiber-derived and mucin-derived oligo-
and polysaccharides, it is likely that during long-term coloniza-
tion, E. coli depends on the anaerobes in mucus that can degrade
oligo- and polysaccharides, e.g.,Bacteroides thetaiotaomicron (41),
to provide them with the mono- and disaccharides they use for
growth. We hypothesized (13) that during the initiation phase of
large-intestine colonization, a commensal E. coli strain enters an
initiation niche in mucus in which it competes for nutrients from
a perfectly mixed pool with any other E. coli strain present in that
niche. We propose that it is in this niche that E. coli Nissle 1917 is
a better colonizer than E. coli Nissle 1917 ppsA pckA between
day 1 and day 5 postfeeding, because E. coli Nissle 1917 is able to
use both glycolytic and gluconeogenic nutrients for growth, and it
is in this niche that E. coli Nissle 1917 competes with invading E.
coli EDL933 for both glycolytic and gluconeogenic nutrients. We
also hypothesized that in addition to continuously colonizing the
initiation niche during long-term colonization, each commensal
E. coli strain also resides on a long-term basis as a member of the
mixed biofilms we see in mucus (12, 13), together with specific
anaerobes. We called the mixed biofilms “restaurants,” and we
hypothesized that each commensal E. coli strain receives mono-
and disaccharides locally from specific anaerobes with which it
interacts physically andmetabolically rather than from a perfectly
mixed pool of nutrients and as such does not compete directly
with any other E. coli strain within its “restaurant.” We hypothe-
size that these biofilms, presumably formed by 5 days postfeeding,
constitute the larger niche, which is colonized equally well by E.
coli Nissle 1917 and E. coli Nissle 1917 ppsA pckA, because
sufficient glycolytic nutrients are made available locally by the
anaerobes residing there such that any gluconeogenic nutrients
FIG 6 Colonization of the intestines of streptomycin-treated mice by pread-
ministered E. coliNissle 1917ppsApckA, E. coliEDL933, and E. coliEDL933
ppsA pckA. (A) Three sets of 3 mice were fed 105 CFU of E. coliNissle 1917
Strr ppsA pckA on day 0 () and 105 CFU each of E. coli EDL933 Strr Rifr
() and E. coli EDL933 StrrppsApckA (Œ) on day 10 postfeeding. (B) Two
sets of 3 mice were fed 105 CFU of E. coli MG1655 Strr ppsA pckA on day 0
() and 105 CFU of E. coli EDL933 Strr ppsA pckA (Œ) on day 10 postfeed-
ing. At the indicated times, fecal samples were homogenized, diluted, and
plated as described in Materials and Methods. Data are mean log10 CFU per
gram of feces for each time point; error bars represent standard errors.
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produced are not needed by E. coli Nissle 1917 for growth and
therefore diffuse to the smaller initiation niche.
Different E. coli strains use different glycolytic nutrients to col-
onize the intestines of streptomycin-treated mice (14, 37). We
recently reported that when mice were precolonized with E. coli
HS, a human commensal strain, and E. coli Nissle 1917, which
together use 5 of 7 known glycolytic nutrients used by E. coli
EDL933 to colonize (14), invading E. coli EDL933 bacteria were
completely eliminated from the mouse intestine (14). However,
precolonizing E. coli HS and E. coli Nissle 1917 were unable to
eliminateE. coliCFT073, a uropathogenicE. coli (UPEC) strain, or
E. coliE2348/69, an enteropathogenicE. coli (EPEC) strain (14). In
fact, both pathogens grew to levels of about 108 CFU/g of feces
under these conditions (14). Although the possibility exists that E.
coli CFT073 and E. coli E2348/69 use several glycolytic nutrients
that E. coli HS and E. coli Nissle 1917 do not use to colonize the
mouse intestine, thus allowing their growth, the data presented
here raise the possibility that different E. coli pathogens may also
use different gluconeogenic nutrients that contribute to their abil-
ity to colonize in the face of competition from commensal strains.
Further research is required to test this possibility.
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